Though the name may be different, it is still the same old sleeping drug Lunesta that has been named differently once it is approved for distribution in Europe. Sepracor is reportedly planning to penetrate the Europe market to help insomniacs residing here. However, Lunesta is already a familiar brand and perhaps changing it catered towards the Europeans can help ease the impressions that some have seen as negative due to some issues.
The Committee for Medicinal Products for Human Use gave a
